Sign up to save your podcasts
Or
Share Pertuzumab and the Curious Case of Accelerated Registration
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pertuzumab and the Curious Case of Accelerated Registration
Drs Kathy Miller, Clifford Hudis, and George Sledge discuss the pros and cons of testing novel breast cancer treatments in the neoadjuvant setting, with special reference to pertuzumab.
View all episodes
By MedscapeDrs Kathy Miller, Clifford Hudis, and George Sledge discuss the pros and cons of testing novel breast cancer treatments in the neoadjuvant setting, with special reference to pertuzumab.